STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity
J. Wang, S. Li, M. Wang, X. Wang, S. Chen, Z. Sun, X. Ren, G. Huang, B. D. Sumer, N. Yan, Y.-x. Fu, J. Gao
A 'shock-and-lock' nanoparticle agonist activates STING in type 1 conventional dendritic cells to enhance antitumor immunity with associated biomarkers.
bioRxiv · Jan 2, 2024Immunology